Covered recipient · General Payments record
FRANCES JACINTO ACOSTA
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$4,506.94
- Reported across 124 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,494.24 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $353.36 | 5 |
| Genentech USA, Inc. | $150.00 | 1 |
| Amgen Inc. | $144.66 | 13 |
| ABBVIE INC. | $138.32 | 3 |
| Harrow Eye, LLC | $125.00 | 1 |
| Apellis Pharmaceuticals, Inc. | $124.45 | 1 |
| Dompe US, Inc. | $122.13 | 1 |
| Regeneron Healthcare Solutions, Inc. | $110.25 | 1 |
| GLAUKOS CORPORATION | $99.66 | 1 |
| Bausch & Lomb Americas Inc. | $76.19 | 4 |
| Mallinckrodt Hospital Products Inc. | $26.40 | 1 |
| Tarsus Pharmaceuticals, Inc. | $23.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $125.00 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103976486 | CMS |
| ABBVIE INC. | $5.55 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103976488 | CMS |
| ABBVIE INC. | $7.77 | 12/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103976490 | CMS |
| Alcon Vision LLC | $15.90 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110650765 | CMS |
| Alcon Vision LLC | $1.00 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110650763 | CMS |
| Alcon Vision LLC | $39.91 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110650767 | CMS |
| Alcon Vision LLC | $146.55 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110650769 | CMS |
| Alcon Vision LLC | $150.00 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110650771 | CMS |
| Amgen Inc. | $17.83 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111509105 | CMS |
| Amgen Inc. | $11.18 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111509103 | CMS |
| Amgen Inc. | $15.13 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111509107 | CMS |
| Amgen Inc. | $11.19 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111509109 | CMS |
| Amgen Inc. | $3.44 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111509111 | CMS |
| Amgen Inc. | $3.21 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111509113 | CMS |
| Amgen Inc. | $3.59 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111509115 | CMS |
| Amgen Inc. | $10.83 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111509119 | CMS |
| Amgen Inc. | $12.60 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111509121 | CMS |
| Amgen Inc. | $3.49 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111509117 | CMS |
| Amgen Inc. | $23.06 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111509123 | CMS |
| Amgen Inc. | $24.99 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111509125 | CMS |
| Amgen Inc. | $4.12 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111509127 | CMS |
| Apellis Pharmaceuticals, Inc. | $124.45 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154021111 | CMS |
| Bausch & Lomb Americas Inc. | $15.27 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140345174 | CMS |
| Bausch & Lomb Americas Inc. | $22.13 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140345176 | CMS |
| Bausch & Lomb Americas Inc. | $22.13 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140345180 | CMS |
| Bausch & Lomb Americas Inc. | $16.66 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140345178 | CMS |
| Dompe US, Inc. | $122.13 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151403216 | CMS |
| Genentech USA, Inc. | $150.00 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133011782 | CMS |
| Glaukos Corporation | $99.66 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151982784 | CMS |
| Harrow Eye, LLC | $125.00 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145605540 | CMS |
| Mallinckrodt Hospital Products Inc. | $26.40 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145086763 | CMS |
| Regeneron Healthcare Solutions, Inc. | $110.25 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114075524 | CMS |
| Tarsus Pharmaceuticals, Inc. | $23.82 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139104969 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.